RHENMAN & PARTNERS ASSET MANAGEMENT AB – Allogene Therapeutics, Inc. Transaction History
RHENMAN & PARTNERS ASSET MANAGEMENT AB portfolio value:
$3.50M
portfolio value
RHENMAN & PARTNERS ASSET MANAGEMENT AB quarter portfolio value change:
-5.26%
quarter
Allogene Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.86% | -10K shares | -488K | $10.8 | 340K |
| Q2 2022 | share | Increase | 0.00% | 350K shares | 3.99M | $11.4 | 350K |